When did ROIVANT SCIENCES LTD (ROIV) report earnings last quarter?
ROIVANT SCIENCES LTD (ROIV) last reported earnings on 2/6/2026.
NASDAQ:ROIV • BMG762791017
Past quarterly earnings results for ROIVANT SCIENCES LTD (ROIV), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2026 | -0.38 | -0.32 | -17.28% | -265.22% | 1.999M | 6.602M | -69.72% | -84.03% |
| Q2 2026 | -0.17 | -0.34 | 50.15% | 45.16% | 1.571M | 7.086M | -77.83% | -64.89% |
| Q1 2026 | -0.33 | -0.32 | -4.36% | -375.00% | 2.17M | 7.379M | -70.59% | -96.06% |
| Q4 2025 | -0.29 | -0.31 | 7.69% | -52.63% | 7.57M | 55.156M | -86.28% | -73.83% |
| Q3 2025 | 0.23 | -0.29 | 180.12% | 176.67% | 12.52M | 16.31M | -23.24% | -66.29% |
| Q2 2025 | -0.31 | -0.26 | -18.60% | 22.50% | 4.475M | 50.205M | -91.09% | -87.94% |
| Q1 2025 | 0.12 | -0.27 | 145.25% | 131.58% | 55.132M | 32.131M | 71.59% | 154.96% |
| Q4 2024 | -0.19 | -0.31 | 38.59% | 5.00% | 28.93M | 32.144M | -10.00% | 5.68% |
| Q3 2024 | -0.30 | -0.33 | 8.09% | 38.78% | 37.14M | 32.727M | 13.48% | 117.83% |
| Q2 2024 | -0.40 | -0.31 | -27.09% | 4.76% | 37.101M | 27.427M | 35.27% | 196.10% |
| Q1 2024 | -0.38 | -0.30 | -25.18% | 20.83% | 21.624M | 25.569M | -15.43% | 400.56% |
| Q4 2023 | -0.20 | -0.37 | 45.72% | 25.93% | 27.376M | 21.957M | 24.68% | 196.92% |
| Q3 2023 | -0.49 | -0.39 | -24.27% | -19.51% | 17.05M | 15.08M | 13.06% | -29.95% |
| Q2 2023 | -0.42 | -0.42 | 0.92% | -31.25% | 12.53M | 6.516M | 92.30% | -10.44% |
| Q1 2023 | -0.48 | -0.33 | -45.52% | - | 4.32M | 8.596M | -49.74% | -44.19% |
| Q4 2022 | -0.27 | -0.33 | 17.90% | - | 9.22M | 13.615M | -32.28% | -39.14% |
| Q3 2022 | -0.41 | -0.25 | -61.04% | - | 24.34M | 10.063M | 141.88% | 323.30% |
| Q2 2022 | -0.32 | -0.23 | -41.00% | - | 13.99M | 5.403M | 158.93% | 959.85% |
| Q1 2022 | - | - | 7.74M | - | 389.87% | |||
| Q4 2021 | - | - | 15.15M | - | 163.48% | |||
| Q3 2021 | -0.41 | - | - | 5.75M | - | 334.62% | ||
| Q2 2021 | - | - | 1.32M | - | -16.24% | |||
| Q1 2021 | - | - | 1.58M | - | - | |||
| Q4 2020 | - | - | 5.75M | - | - | |||
| Q3 2020 | - | - | 1.323M | - | - | |||
| Q2 2020 | - | - | 1.576M | - | - |
Notes
ROIVANT SCIENCES LTD (ROIV) last reported earnings on 2/6/2026.
ROIVANT SCIENCES LTD (ROIV) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, ROIVANT SCIENCES LTD (ROIV) has beaten EPS estimates in 2 out of 4 releases.